investiment.io
CAMP4 Therapeutics Corporation
$4.41
0.67 (17.91%)
CAMP4 Therapeutics Corporation
$4.41
0.67 (17.91%)
CAMP Price Chart
| Basic | |
|---|---|
| Market Cap | $85.83M |
| Price | $4.41 |
| 52 Week Range | 3.5-12.3 |
| Beta | 1.76 |
| Margins | |
| Gross Profit Margin | 34.61% |
| Operating Profit Margin | -75.11% |
| Net Profit Margin | -77.36% |
| Valuation (TTM) | |
| P/E Ratio | -1.85 |
| Price to Sales Ratio | 0.77 |
| Price to Book Ratio | -2.23 |
| PEG Ratio | 0.00 |
Industry
Biotechnology
Sector
Healthcare
Full-Time Employees
58
Website
IPO Date
2024-10-11T00:00:00.000Z
Description
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Phone
617-651-8867
Address
One Kendall Square Bldg 1400 West, 3rd Floor, Cambridge, MA, 02139, US
CIK
0001736730